openPR Logo
Press release

Valsartan Drug Market Overview and Growth Rate Analysis 2018-2023 by Leading Companies: Novartis, Sun Pharmaceutical, Teva, Mylan, Alembic Pharmaceuticals, Lupin, Aurobindo Pharma

12-17-2018 09:02 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Report Hive Research

Valsartan Drug Market Overview and Growth Rate Analysis

“Valsartan (trade name Diovan, Novartis International AG) is mainly used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack. It is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT1) angiotensin receptor.”

Global Valsartan Drug Market report explores manufacturer’s competitive scenario and provides market share for all major players of this market based on production capacity, sales, revenue, geographical presence and other major factors. The report also covers import/export data across all major regions covered in this report.

Download PDF Sample Of this Report @ https://www.reporthive.com/enquiry.php?id=1688984&req_type=smpl

Valsartan Drug report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

The Key Players Covered in this report:
• Novartis
• Sun Pharmaceutical
• Teva
• Mylan
• Alembic Pharmaceuticals
• Lupin
• Aurobindo Pharma and More....

Key Questions Answered in this Report

• What will the market size be in 2023 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?

If you have any special requirements, please let us know and we will offer you the report as you want.

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7.
• 40 mg Tablets
• 80 mg Tablets
• 160 mg Tablets
• 320 mg Tablets

Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2023 in section 11.8.
• Hypertension
• Heart Failure
• Heart Attack

Click Here for Purchase Full Report with Full TOC @ https://www.reporthive.com/enquiry.php?id=1688984&req_type=purch

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics

• It provides a forward looking perspective on different factors driving or restraining market growth

• It provides a Five-year forecast assessed on the basis of how the market is predicted to grow

• It helps in understanding the key product segments and their future

• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Table of Contents
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Valsartan Drug Consumption 2013-2023
2.1.2 Valsartan Drug Consumption CAGR by Region
2.2 Valsartan Drug Segment by Type
2.2.1 40 mg Tablets
2.2.2 80 mg Tablets
2.2.3 160 mg Tablets
2.2.4 320 mg Tablets
2.3 Valsartan Drug Consumption by Type
2.3.1 Global Valsartan Drug Consumption Market Share by Type (2013-2018)

3 GLOBAL VALSARTAN DRUG BY PLAYERS
3.1 Global Valsartan Drug Sales Market Share by Players
3.1.1 Global Valsartan Drug Sales by Players (2016-2018)
3.1.2 Global Valsartan Drug Sales Market Share by Players (2016-2018)
3.2 Global Valsartan Drug Revenue Market Share by Players
3.2.1 Global Valsartan Drug Revenue by Players (2016-2018)

4 Valsartan Drug by Regions
4.1 Valsartan Drug by Regions
4.1.1 Global Valsartan Drug Consumption by Regions
4.1.2 Global Valsartan Drug Value by Regions
4.2 Americas Valsartan Drug Consumption Growth
4.3 APAC Valsartan Drug Consumption Growth
TOC Continued….!

Tables And Figures
• Figure Picture of Valsartan Drug
• Table Product Specifications of Valsartan Drug
• Figure Valsartan Drug Report Years Considered
• Figure Market Research Methodology
• Figure Global Valsartan Drug Consumption Growth Rate 2013-2023 (K Units)
• Figure Global Valsartan Drug Value Growth Rate 2013-2023 ($ Millions)
• Table Valsartan Drug Consumption CAGR by Region 2013-2023 ($ Millions)
• Figure Product Picture of 40 mg Tablets and More….

About Report Hive Research
Report Hive Research delivers strategic market research reports, statistical survey, and Industry analysis & forecast data on products & services, markets and companies. Our clientele ranges mix of global Business Leaders, Government Organizations, SME’s, Individual & Start-ups, Management Consulting Firms, and Universities etc. Our library of 600,000+ market reports covers industries like Chemical, Healthcare, IT, Telecom, Semiconductor, etc. in the USA, Europe Middle East, Africa, Asia Pacific. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales & revenue, technology trends, competitive analysis, product portfolio & application analysis etc.

500, North Michigan Avenue,
Suite 6014
Chicago, IL - 60611
United States

Contact Us
Mike Ross
Marketing Manager
sales@reporthive.com
https://www.reporthive.com
Phone Number: +1-312 604 7084

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Valsartan Drug Market Overview and Growth Rate Analysis 2018-2023 by Leading Companies: Novartis, Sun Pharmaceutical, Teva, Mylan, Alembic Pharmaceuticals, Lupin, Aurobindo Pharma here

News-ID: 1445637 • Views:

More Releases from Report Hive Research

Oryzenin Market 2022 scope and Research methodology | Axiom Foods, Inc., AIDP
Oryzenin Market 2022 scope and Research methodology | Axiom Foods, Inc., AIDP
The global Oryzenin market is expected to reach an estimated USD 561.1 Million by 2030 with a CAGR of 14.2% from 2022 to 2030. The Global Oryzenin market 2022 research provides a overview of the industry including definitions, classifications, applications and industry chain structure. The Global Oryzenin market report is provided for the US, EU, APAC, as well as development trends, competitive landscape analysis, and key regions development status. Development policies
Polymer Emulsions Market SWOT Analysis, Competitive Landscape and Massive Growth 2022 | BASF, Dow, Trinseo(Styron)
Polymer Emulsions Market SWOT Analysis, Competitive Landscape and Massive Growth …
The global Polymer Emulsions market was estimated at USD 27.3 billion in 2021 and is projected to expand at a CAGR of 7.5% from 2022 to 2030. The Report Hive Research has added a new statistical market report to its repository titled as, Polymer Emulsions Market. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data
Glufosinate Market Future Set to Significant Growth with High CAGR value 2022 | Bayer CropScience, Lier Chemical, Zhejiang YongNong
Glufosinate Market Future Set to Significant Growth with High CAGR value 2022 | …
The global Glufosinate market is expected to reach an estimated USD 4.12 billion by 2030 with a CAGR of 8.68% from 2022 to 2030. The Glufosinate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product
Glass Filled Nylon Market 2022 scope and Research methodology | DowDuPont, BASF, Asahi Kasei
Glass Filled Nylon Market 2022 scope and Research methodology | DowDuPont, BASF, …
The global Glass Filled Nylon market is projected to register an average CAGR of 5.6% during the forecast period 2022-2030. The Global Glass Filled Nylon market 2022 research provides a overview of the industry including definitions, classifications, applications and industry chain structure. The Global Glass Filled Nylon market report is provided for the US, EU, APAC, as well as development trends, competitive landscape analysis, and key regions development status. Development policies

All 5 Releases


More Releases for Valsartan

Sacubitril Valsartan Sodium Market Key Players, Share and Forecast Outlook
"The global market for Sacubitril Valsartan Sodium, a critical medication for heart failure and related cardiovascular conditions, is valued at approximately $4.2 billion in 2024. Projections indicate a substantial growth trajectory, with an anticipated market value reaching around $7.5 billion by 2034. This reflects a robust Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period from 2025 to 2034." Exactitude Consultancy., Ltd. released a research report titled "Sacubitril Valsartan
Sacubitril Valsartan Sodium Market Key Players, Share and Forecast Outlook
"The global market for Sacubitril Valsartan Sodium, a critical medication for heart failure and related cardiovascular conditions, is valued at approximately $4.2 billion in 2024. Projections indicate a substantial growth trajectory, with an anticipated market value reaching around $7.5 billion by 2034. This reflects a robust Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period from 2025 to 2034." Exactitude Consultancy., Ltd. released a research report titled "Sacubitril Valsartan
Valsartan Drug Market Size and Forecast
Valsartan Drug Market size was valued at USD 31.76 Billion in 2023 and is expected to reach USD 43.18 Billion by the end of 2030 with a CAGR of 4.1% During the Forecast Period 2024-2030. Valsartan Drug Market Outlook and Investment Analysis What is the current outlook for the Valsartan drug market? The Valsartan drug market is experiencing growth driven by the increasing prevalence of hypertension and cardiovascular diseases globally. Valsartan, an angiotensin
Valsartan Manufacturing Plant Project Report 2023, Operating Costs and Profit Pr …
IMARC Group's report titled "Valsartan Manufacturing Plant Project Report 2023: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" provides a comprehensive guide for establishing a valsartan manufacturing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more. In addition to the
Valsartan Market Analysis, Revenue, Price, Market Share, Growth Rate, Forecast 2 …
Los Angeles, United States December 2022,- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Valsartan market. It sheds light on how the global Valsartan market is expected to grow during the course of the forecast period. With SWOT analysis and Porter's Five Forces analysis, it gives a deep explanation of the strengths and weaknesses of the global Valsartan market
Valsartan Tablets Market: Competitive Dynamics & Global Outlook 2025
LP INFORMATION offers a latest published report on Valsartan Tablets Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This intelligence Valsartan Tablets Market report by LP INFORMATION includes investigations based on the current scenarios, historical records, and future predictions. An accurate data of various aspects such as type, size, application, and end user have been scrutinized in this research report.